newsfilter
← Latest News
PR Newswire·

Q32 Bio and Homology Medicines Announce Merger Agreement

Q32 Bio Inc., a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, and Homology Medicines, Inc....